Active ingredient
Selpercatinib
6 finished FDA listings contain Selpercatinib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- SELPERCATINIB
- Dosage forms
- Capsule, Tablet, Coated
- Routes
- Oral
- Manufacturers / labelers
- 1
- Strengths listed
- 120 mg/1 · 160 mg/1 · 40 mg/1 · 80 mg/1
- Brand names in FDA listings
- Retevmo
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2370147
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 213246 | ELI LILLY AND CO | 2020-05-08 | 2 |
| NDA 218160 | ELI LILLY AND CO | 2024-04-10 | 4 |
Official labeling on DailyMed
No DailyMed labels matched by set ID.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.